The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

Since starting on the medication, she has not had a relapse, and she said she "jumped" at the chance to try out the new injection. "It's exactly the same treatment, just through a different method ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo.

New migraine medicines ... these act more quickly than oral medications? AS: Exactly, because they can access the bloodstream ...